Vertex Pharmaceuticals Eyes New Highs After Q4 Earnings Surprise
VRTX's Q4 earnings missed expectations, yet revenue exceeded forecasts, highlighting strong CF sales and new product momentum.
Yahoo Finance · 4 min read
VRTX Vertex Pharmaceuticals
Healthcare
Biotechnology
Latest news and analysis for Vertex Pharmaceuticals (VRTX).
Current Price
$486.03
-10.80
(-2.17%)
Market data may be delayed
Price Chart
Loading chart...
All Articles for VRTX
Yahoo Finance · 4 min read
Analyst Take: Vertex Pharmaceuticals Posts Strong Q4 2025 Earnings
VRTX's Q4 2025 earnings beat expectations, raising questions about future growth. Discover the implications for Vertex Pharmaceuticals and investors.
Yahoo Finance · 4 min read
Vertex Pharmaceuticals Surprises Wall Street With Strong Q4 Metrics
VRTX posted surprising Q4 results that exceeded analyst expectations, showcasing strong financial performance. Here’s what that means for investors.
Yahoo Finance · 4 min read